The Serogroup B Meningococcal Vaccine Bexsero Elicits Antibodies to Neisseria gonorrhoeae
EA Semchenko, A Tan, R Borrow… - Clinical Infectious …, 2019 - academic.oup.com
Abstract Background Neisseria gonorrhoeae and Neisseria meningitidis are closely-related
bacteria that cause a significant global burden of disease. Control of gonorrhoea is …
bacteria that cause a significant global burden of disease. Control of gonorrhoea is …
A meningococcal B vaccine induces cross-protection against gonorrhea
RFO Azze - Clinical and experimental vaccine research, 2019 - synapse.koreamed.org
Purpose Neisseria meningitidis and Neisseria gonorrhoeae share between 80% and 90% of
their genetic sequence. Meningococcal serogroup B vaccines based on outer membrane …
their genetic sequence. Meningococcal serogroup B vaccines based on outer membrane …
Cross-protection induced by VA-MENGOC-BC® vaccine
RF Ochoa-Azze - Human vaccines & immunotherapeutics, 2018 - Taylor & Francis
ABSTRACT I would like to comment on the article “Commentary: Impact of meningococcal
group B OMV vaccines, beyond their brief”, DOI: 10.1080/21645515.2017. 1381810. The …
group B OMV vaccines, beyond their brief”, DOI: 10.1080/21645515.2017. 1381810. The …
[PDF][PDF] Mucosal approaches in Neisseria vaccinology
J Balboa, B Romeu, M Baró, C Campa, MI Lantero… - VacciMonitor, 2009 - redalyc.org
Meningococcal B strains accounts for some 72% and 28% of meningococcal diseases in
infants and toddlers of Europe and in the USA, respectively (1, 2). Nevertheless …
infants and toddlers of Europe and in the USA, respectively (1, 2). Nevertheless …
[HTML][HTML] Adjuvants Derived from Neisseria meningitidis Serogroup B Induce a Cross Reactive Response against Neisseria gonorrhoeae in Mice
Introduction: Neisseria is a large genus of bacteria that colonize mucosal surfaces. Of the 11
species that colonize humans, only two are pathogens, N. meningitidis and N. gonorrhoeae …
species that colonize humans, only two are pathogens, N. meningitidis and N. gonorrhoeae …
Influencia de las vías de inmunización mucosales sobre la protección contra herpes simple tipo 2 con el AFCo1 como adyuvante
Las vacunas mucosales se han planteado como una estrategia prometedora para inducir
protección mucosal. El virus herpes simple tipo 2 es uno de los patógenos más frecuentes …
protección mucosal. El virus herpes simple tipo 2 es uno de los patógenos más frecuentes …
Enfoques mucosales en vacunologia de Neisseria
Meningococcal B strains accounts for some 72% and 28% of meningococcal diseases in
infants and toddlers in Europe and the USA, respectively. Nevertheless, meningococcal …
infants and toddlers in Europe and the USA, respectively. Nevertheless, meningococcal …
Influence of mucosal immunization routes on herpes simplex virus type 2 protection with AFCol as adjuvant
Mucosal vaccines are a promising strategy to induce mucosal protection. Herpes simplex
virus type 2 is the commonest pathogens in the human transmitted by exposure at the …
virus type 2 is the commonest pathogens in the human transmitted by exposure at the …